Marisa Nielsen

Dr. Marisa Nielsen

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Harmful Algae
Verified
Journal Article
Closed access
MNMarisa Nielsen
Marisa Nielsen
SJSunny C. Jiang
Sunny C. Jiang

1 August 2019 in Marine Pollution Bulletin
Verified
Journal Article
Closed access
MNMarisa Nielsen
Marisa Nielsen
Sunny JiangSunny Jiang
Sunny Jiang

1 June 2021 in Environmental Research
Verified
Journal Article
Closed access
MNMarisa Nielsen
Marisa Nielsen
NWNan Wang
Nan Wang
SJSunny C. Jiang
Sunny C. Jiang

1 February 2021 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
XXXuping Xie
Xuping Xie
MNMarisa Nielsen
Marisa Nielsen
AMAntonio E. Muruato
Antonio E. Muruato
CFCamila R. Fontes-Garfias
Camila R. Fontes-Garfias
PRPing Ren
Ping Ren

24 October 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
MNMarisa Nielsen
Marisa Nielsen
FCFilipe M Cerqueira
Filipe M Cerqueira
SKSri Bharathi Kavuri
Sri Bharathi Kavuri
CRCaitlin M Raymond
Caitlin M Raymond
AMAeman Muneeb
Aeman Muneeb
PRPing Ren
Ping Ren
Mucormycosis is a severe and potentially life-threatening infection caused by a group of fungi classified as mucormycetes within the scientific order Mucorales. These infections are characterized by rapid and invasive fungal growth, presenting significant treatment challenges. Here we present 5 cases encountered from 2018 to 2022 at the University of Texas Medical Branch in Galveston, Texas, including a novel Apophysomyces species. These cases illustrate the diverse clinical manifestations of mucormycosis, including pulmonary, rhino-cerebral, gastrointestinal, and soft tissue involvement. Our investigation incorporates information provided by a multidisciplinary team of clinical collaborators, emphasizing the findings from radiology, histopathology, and microbiology. Given the escalating global incidence of mucormycosis, it is crucial for clinicians to become familiar with associated clinical findings, comorbidities, and risk factors to facilitate prompt recognition, appropriate diagnostic testing, and timely initiation of treatment.

23 February 2022 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
MNMarisa Nielsen
Marisa Nielsen
RMRafael Rahal Guaragna Machado
Rafael Rahal Guaragna Machado
BMBrooke Mitchell
Brooke Mitchell
AMAllan J. McConnell
Allan J. McConnell
NSNehad I. Saada
Nehad I. Saada
PRPing Ren
Ping Ren